Current Report · Items 2.02, 9.01 · 8-K

NRX Pharmaceuticals, Inc.

NRXPNASDAQEQUITYCurrent

Results of Operations and Financial Condition

Filed Aug 17, 2026Accepted Aug 17, 2026, 8:00 AM EDTCIK 1719406Accession 0001437749-26-028111

View company →Permanent SEC source ↗

Company context

Current securities

NRXPNASDAQ · EQUITY · Current

Historical securities (9)

Recent company filings

Registered securities in this filing

NRX PHARMACEUTICALS, INC. · 8-K · Filed 2026-08-17

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock

Symbol: NRXP
Exchange: NASDAQ
Classification: COMMON
Status: Current

Filing context

Context: d20268K

Dimensions: Not supplied

Accession 000143774926028111 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 2.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations

Item 2.02 Results of Operations and Financial Condition. On August 17, 2026, NRx Pharmaceuticals, Inc. (the “Company”) announced via press release its results for the second quarter ended June 30, 2026. A copy of the Company’s press release is hereby furnished and incorporated herein by reference as Exhibit 99.1. Item 9.01. Financial Statements and Exhibits. Exhibit Description No. ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── 99.1 Press Release dated August 17, 2026. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

Get the free weekly BCS email.